Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -210.75% is 59% above its 5-year average of -509.98%, near the high end of its 5-year range (-5982.80%–-111.69%).
14.58% above its 12-month average of -246.71%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -238.17%.
NET PROFIT MARGIN
-210.75%
NET PROFIT MARGIN AVG TTM
-246.71%
NET PROFIT MARGIN AVG 3Y
-319.85%
NET PROFIT MARGIN AVG 5Y
-509.98%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+14.58%
CURRENT VS 3Y AVG
+34.11%
CURRENT VS 5Y AVG
+58.68%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-80957.69%
vs the sector median at left
Hyperfine, Inc.
Market Cap
$73.77M
Net Profit Margin
-210.75%
TTM Avg
-246.71%
3Y Avg
-319.85%
5Y Avg
-509.98%
Market Cap
$75.18M
Net Profit Margin
-55.03%
TTM Avg
-63.48%
3Y Avg
-81.34%
5Y Avg
-87.39%
Market Cap
$72.60M
Net Profit Margin
-105.29%
TTM Avg
-106.48%
3Y Avg
-112.00%
5Y Avg
-95.88%
Market Cap
$73.10M
Net Profit Margin
-102.84%
TTM Avg
-531.21%
3Y Avg
-660.25%
5Y Avg
-488.89%
Market Cap
$75.82M
Net Profit Margin
-9.79%
TTM Avg
-5.93%
3Y Avg
-6.23%
5Y Avg
-32.51%
Market Cap
$76.50M
Net Profit Margin
-155404.38%
TTM Avg
-155404.38%
3Y Avg
-155404.38%
5Y Avg
-155404.38%
Market Cap
$70.59M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-13227.36%
5Y Avg
-12286.00%
Market Cap
$76.75M
Net Profit Margin
-63.06%
TTM Avg
-90.45%
3Y Avg
-113.67%
5Y Avg
-137.76%
Market Cap
$77.72M
Net Profit Margin
-47475.71%
TTM Avg
-41070.98%
3Y Avg
-27618.26%
5Y Avg
-38759.83%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hyperfine, Inc. (HYPR) | $73.77M | -210.75% | -246.71% | -319.85% | -509.98% |
| Pulmonx Corporation (LUNG)vs › | $75.18M | -55.03% | -63.48% | -81.34% | -87.39% |
| MindWalk Holdings Corp. (HYFT)vs › | $72.60M | -105.29% | -106.48% | -112.00% | -95.88% |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $73.10M | -102.84% | -531.21% | -660.25% | -488.89% |
| SkinHealth Systems Inc. (SKIN)vs › | $75.82M | -9.79% | -5.93% | -6.23% | -32.51% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $76.50M | -155404.38% | -155404.38% | -155404.38% | -155404.38% |
| Gain Therapeutics, Inc. (GANX)vs › | $70.59M | 0.00% | 0.00% | -13227.36% | -12286.00% |
| Outset Medical, Inc. (OM)vs › | $76.75M | -63.06% | -90.45% | -113.67% | -137.76% |
| Sera Prognostics, Inc. (SERA)vs › | $77.72M | -47475.71% | -41070.98% | -27618.26% | -38759.83% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $77.73M | -130000.00% | -89627.13% | -49555.20% | -36262.68% |
Operating Margin
-273.4%
Net Profit Margin
-210.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -238.17% |
| 2026-03-31 | -220.93% |
| 2025-12-31 | -111.69% |
| 2025-09-30 | -320.60% |
| 2025-06-30 | -342.17% |
| 2025-03-31 | -440.71% |
| 2024-12-31 | -447.65% |
| 2024-09-30 | -283.45% |
| 2024-06-30 | -279.70% |
| 2024-03-31 | -298.88% |
| 2023-12-31 | -397.77% |
| 2023-09-30 | -461.67% |
| 2023-06-30 | -314.61% |
| 2023-03-31 | -461.48% |
| 2022-12-31 | -917.06% |
| 2022-09-30 | -560.95% |
| 2022-06-30 | -1506.46% |
| 2022-03-31 | -1575.75% |
| 2021-12-31 | -5982.80% |
| 2021-09-30 | -4418.33% |
| 2021-06-30 | -4072.63% |
| 2021-03-31 | -2354.68% |
| 2020-12-31 | -3314.98% |
| 2020-09-30 | -15329.73% |
| 2020-06-30 | -21786.00% |
| 2020-03-31 | -21786.00% |
